Regulus Therapeutics reported $60.92M in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Astrazeneca AZN:US 157.61B 26.53B
AstraZeneca AZN:LN 113.99B 18.86B
Biogen BIIB:US $ 52.13B 9.52B
Celldex Therapeutics CLDX:US $ 1.32B 508.65M
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Gilead Sciences GILD:US $ 86.36B 4.99B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Intrexon XON:US $ 1.35B 76.37M
Lexicon Pharmaceuticals LXRX:US $ 662.74M 184.62M
Ligand Pharmaceuticals LGND:US $ 2.18B 347.98M
Merk MRK:US $ 196918.18M 1780.24M
Omeros OMER:US $ 924.95M 177.47M
Regulus Therapeutics RGLS:US $ 60.92M 52.19M
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Sanofi SNY:US 132.07B 7.67B
Spectrum Pharmaceuticals SPPI:US $ 615.4M 114.24M
Takeda 4502:JP 5869.99B 411.92B
Vital Therapies VTL:US $ 266.65M 70.77M
YTE INCY:US $ 18.5B 632.77M